Viral Vectors And Plasmid DNA Market Growth Trends: Moderate Expansion with 6.6% CAGR Until 2030

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Forecasted Market Size of the Viral Vectors And Plasmid DNA Market by 2030?
The viral vectors and plasmid dna market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to limited availability of viral vectors, reliance on research-grade plasmid dna, increasing gene therapy pipelines, growing biopharmaceutical r&d activities, adoption of conventional viral vector platforms.

The viral vectors and plasmid dna market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to development of clinical-grade and gmp plasmid dna, expansion of viral vector applications in cancer and infectious diseases, rising investment in gene therapy, growing demand for immunotherapy solutions, adoption of novel vector platforms such as aav and lentiviral vectors. Major trends in the forecast period include rising adoption of plasmid dna and viral vectors in gene therapy, expansion of viral vector platforms for cancer and genetic disorder treatments, growth in gmp-grade plasmid dna production for clinical applications, increasing research on novel adeno-associated and lentiviral vectors, integration of plasmid dna and viral vectors in immunotherapy and vaccine development.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Which Major Growth Factors Are Shaping the Viral Vectors And Plasmid DNA Market?
The increasing incidence of tuberculosis cases is expected to propel the growth of the viral vector and plasmid DNA market going forward. Tuberculosis (TB) is a contagious and potentially serious infectious disease caused by bacteria. It primarily affects the lungs but can also impact other parts of the body. Plasmid DNA vaccines have been used to deliver microbial antigen-coding genes for tuberculosis. These vaccines can be designed to express specific antigens of Mycobacterium tuberculosis, the bacterium that causes tuberculosis and can be administered through intramuscular injection. For instance, in February 2024, according to the GOV.UK, a UK-based government department, Cases of tuberculosis (TB) in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. Therefore, the increasing incidence of tuberculosis cases is driving the growth of the viral vector and plasmid DNA market.

How Is the Viral Vectors And Plasmid DNA Market Arranged by Segment Classification?
The viral vectors and plasmid dna market covered in this report is segmented –

1) By Product: Plasmid DNA, Viral Vectors
2) By Disease: Infectious Diseases, Genetic Disorders, Cancer, Other Diseases
3) By Application: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications
4) By End User: Research Institutes, Biopharmaceutical And Pharmaceutical Companies

Subsegments:
1) By Plasmid DNA: Research-Grade Plasmid DNA, Clinical-Grade Plasmid DNA, GMP (Good Manufacturing Practice) Plasmid DNA
2) By Viral Vectors: Adenoviral Vectors, Lentiviral Vectors, AAV (Adeno-Associated Virus) Vectors, Retroviral Vectors, Vesicular Stomatitis Virus (VSV) Vectors

Which Trends Are Most Likely to Influence Viral Vectors And Plasmid DNA Market Growth in the Next Decade?
Major companies operating in the viral vectors and plasmid DNA market are increasing their focus on introducing innovative products, such as helper plasmids, to gain a competitive edge in the market. A helper plasmid is a type of plasmid DNA that is used in the production of viral vectors, including adeno-associated viral vectors (AAV), which are commonly used in gene therapy. For instance, in March 2023, Charles River Laboratories International Inc., a US-based pharmaceutical company, launched off-the-shelf pHelper, a helper plasmid that aims to speed up the process from early discovery through commercial manufacture of adeno-associated virus (AAV)-based gene therapy programs and secure supplies. The newest of a broad range of contract development and manufacturing organization (CDMO) goods and services, helper plasmids are designed to protect viral vector packaging in cell and gene therapy operations and streamline convoluted supply chains. Adeno-associated viral vectors (AAV), which are frequently utilized in gene therapy, are created using helper plasmids.

What Are the Top Companies to Watch in the Viral Vectors And Plasmid DNA Market?
Major companies operating in the viral vectors and plasmid dna market are FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza Group AG, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Каnеkа Соrроrаtіоn, Cell and Gene Therapy Catapult, VGXI Inc., MassBiologics, Sanofi, Spark Therapeutics, UniQure NV, Thermo Fisher Scientific, VIROVEK, SIRION Biotech GmbH, ALDEVRON, Oxford BioMedica, PlasmidFactory GmbH & Co. KG, Biovian Oy, BioReliance Corporation, 4D Molecular Therapeutics, Renova Therapeutics, Shenzhen SiBiono GeneTech Co., Vigene Biosciences Inc., Novasep, Genzyme Corporation, Oxford Gene Technology, Richter-Helm, MolMed, Merck KGaA Inc., Catalent Inc., WuXi AppTec, GenScript Biotech Corporation, Eurogentec, Creative Biogene

Get the full viral vectors and plasmid dna market report here:
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Which regions are expected to dominate the Viral Vectors And Plasmid DNA Market during the forecast period?
North America was the largest region in the viral vectors and plasmid DNA market in 2025. The Middle East is expected to be the fastest-growing region in the global viral vectors & plasmid DNA market analysis. The regions covered in the viral vectors and plasmid dna market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company